Hyperimmunization of apo-E-deficient mice with homologous malondialdehyde low-density lipoprotein suppresses early atherogenesis

Atherosclerosis

Volumn 138, Issue 1, 1998, Pages 147-152

  George, Jacob ^a   Afek, Arnon ^a   Gilburd, Boris ^a   Levkovitz, Hana ^a,b   Shaish, Aviv ^a,b   Goldberg, Iris ^a,b   Kopolovic, Yuri ^a,b   Wick, Georg ^c,d   Shoenfeld, Yehuda ^a,b   Harats, Dror ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c ERICH SCHMID INSTITUTE OF MATERIALS SCIENCE   (Austria)

^d INNSBRUCK MEDICAL UNIVERSITY   (Austria)

Author keywords

Antibodies; Apo E; Atherosclerosis; Immune system; Lymphocytes; Malondialdehyde low density lipoprotein; Mouse

Indexed keywords

FREUND ADJUVANT; LOW DENSITY LIPOPROTEIN; MALONALDEHYDE;

ACTIVE IMMUNIZATION; ANIMAL EXPERIMENT; ARTICLE; ATHEROSCLEROSIS; AUTOIMMUNITY; HEART PROTECTION; HYPERLIPOPROTEINEMIA TYPE 3; IMMUNOREGULATION; MOUSE; NONHUMAN; PRIORITY JOURNAL;

ANIMALS; ANTIBODIES; APOLIPOPROTEINS E; ARTERIOSCLEROSIS; FEMALE; IMMUNIZATION; IMMUNOHISTOCHEMISTRY; LIPIDS; LIPOPROTEINS, LDL; MALONDIALDEHYDE; MICE; SINUS OF VALSALVA;

EID: 17444454127     PISSN: 00219150     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0021-9150(98)00015-X     Document Type: Article

References (26)

1. Ross R The pathogenesis of atherosclerosis: a perspective for the l990s. Nature. 362:1993;801-809.
2. Wick G, Schett G, Amberger A, Kleindienst R, Xu Q Is atherosclerosis an immunologically mediated disease? Immunol Today. 16:1995;27-33.
3. Libby P, Hansson GK Involvement of the immune system in human atherogenesis: current knowledge and unanswered questions. Lab Invest. 64:1991;5-15.
4. George J, Harats D, Gilburd B, Shoenfeld Y Emerging cross-regulatory roles of immunity and autoimmunity in atherosclerosis. Immunol Res. 15:1996;315-322.
5. Steinberg D, Parathasarathy S, Carew TE, Khoo JC, Witztum JL Beyond cholesterol. Modifications of low-density lipoprotein that increase its atherogenicity. New Engl J Med. 320:1989;915-924.
6. Witztum J The oxidation hypothesis of atherosclerosis. Lancet. 344:1994;793-795.
7. Xu Q, Wick G The role of heat shock proteins in protection and pathophysiology of the arterial wall. Mol Med Today. 2:1996;272-279.
8. Xu Q, Dietrich H, Steiner HJ, Gown AM, Schoel B, Mikuz G, Kaufman SHE, Wick G Induction of arteriosclerosis in normocholesterolemic rabbits by immunization with heat shock protein 65. Arterioscler Thromb. 12:1992;789-799.
9. Xu Q, Kleindienst W, Waitz H, Dietrich H, Wick G Increased expression of heat shock protein 65 coincides with a population of infiltrating T lymphocytes in atherosclerotic lesions of rabbits specifically responding to heat shock protein 65. J Clin Invest. 91:1993;2693-2702.
10. Palinski W, Miller E, Witztum JL Immunization of low density lipoprotein (LDL) receptor-deficient rabbits with homologous malondialdehyde-modified LDL reduces atherogenesis. Proc Natl Acad Sci USA. 92:1995;821-825.
11. Ameli S, Hultgardh-Nilsson A, Regnstrom J, Calara F, Yano J, Cercek B, Shah PK, Nilsson J Effect of immunization with homologous LDL and oxidized LDL on early atherosclerosis in hypercholesterolemic rabbits. Arterioscler Thromb Vasc Biol. 16:1996;1074-1079.
12. Plump AS, Smith JD, Hayek T, Aalto-Setala K, Walsh A, Verstuyft JG, Rubin EM, Breslow JL Severe hypercholesterolemia and atherosclerosis in apolipoprotein-E deficient mice created by homologous recombination in ES cells. Cell. 71:1992;343-353.
13. Zhang SH, Reddick RL, Piedrahita JA, Maeda N Spontaneous hypercholesterolemia and arterial lesions in mice lacking apolipoprotein E. Science. 258:1992;468-471.
14. Palinski W, Ord VA, Plump AS, Breslow JL, Steinberg D, Witztum JL Apo-E-deficient mice are a model of lipoprotein oxidation in atherogenesis. Demonstration of oxidation-specific epitopes in lesions and high titers of autoantibodies to malondialdehyde-lysine in serum. Arterioscler Thromb. 14:1994;605-616.
15. Reddick RL, Zhang SH, Maeda N Atherosclerosis in mice lacking apo-E. Evaluation of lesional development and progression. Arterioscler Thromb. 14:1994;141-147.
16. Lichtman AH, Cybulsky M, Luscinskas FW Immunology of atherosclerosis: the promise of mouse models. Am J Pathol. 149:1996;351-357.
17. Zhou X, Stemme S, Hansson GK Evidence for a local immune response in atherosclerosis; CD4+ T cells infiltrate lesions of apolipoprotein-E deficient mice. Am J Pathol. 149:1996;359-366.
18. Roselaar SE, Kakkanathu PX, Daugherty A Lymphocyte populations in atherosclerotic lesions of apo-E -/- and LDL receptor -/- mice; decreasing density with disease progression. Arterioscler Thromb Vasc Biol. 16:1996;1013-1018.
19. Palinski W, Yla-Herttuala S, Rosenfeld ME, Butler SW, Socher SA, Parthasarathy S, Curtiss LK, Witztum JL Antisera and monoclonal antibodies specific for epitopes generated during oxidative modification of low density lipoprotein. Arteriosclerosis. 10:1990;325-335.
20. Paigen B, Morrow A, Holmes PA, Mitchell D, Williams RA Quantitative assessment of atherosclerotic lesions in mice. Atherosclerosis. 68:1987;231-240.
21. Rubin EM, Krauss RM, Spangler EA, Verstuyft JG, Clift SM Inhibition of early atherogenesis in transgenic mice by human apoplipoprotein A-I. Nature. 353:1991;265-267.
22. Qiao JH, Xie PZ, Fishbein MC, Kreuzer J, Drake TA, Demer LL, Lusis AJ Pathology of atheromatous lesions in inbred and genetically engineered mice. Genetic determinations of arterial calcification. Arterioscler Thromb. 14:1994;1480-1497.
23. Nakashima Y, Plump AS, Raines EW, Breslow JL, Ross R Apo-E deficient mice develop lesions of all phases of atherosclerosis throughout the arterial tree. Arterioscler Thromb. 14:1994;133-140.
24. Dansky HM, Charlton SA, Harper MM, Smith JD T and B lymphocytes play a minor role in atherosclerotic plaque formation in the apolipoprotein E-deficient mouse. Proc Natl Acad Sci USA. 94:1997;4642-4646.
25. Emeson EE, Shen ML Accelerated atherosclerosis in hyperlipidemic C57BL/6 mice treated with cyclosporin A. Am J Pathol. 142:1993;1906-1915.
26. Roselaar SE, Schonfeld G, Daugherty A Enhanced development of atherosclerosis in cholesterol-fed rabbits by suppression of cell-mediated immunity. J Clin Invest. 96:1995;1389-1394.